Promising new target discovered in pancreatic cancer could boost chemotherapy and reduce spread

A molecule called nidogen-2 may be a key driver of pancreatic cancer progression and metastasis, offering a promising new treatment approach for this aggressive cancer, according to a Garvan Institute study.

This post was originally published on this site

Lawyers Lookup - LawyersLookup.ca